News
News
PublISHED ON
UpDATED ON
Swedish Research Council allocates 25 million SEK to platform for antibiotics development
The Swedish Research Council has decided to allocate 26 million SEK to fund ENABLE-2, a platform for developing antibiotics at Uppsala University, during 2021–2022.
The platform opened on 4 October for new applications. The research to be funded via the platform shall relate to molecules that may be candidates for antibacterial medicines. With support from Vinnova, companies may also apply to use the platform.
See the call from ENABLE-2 for further information.
External link.
MORE WITHIN THE SAME SUBJECT AREA
-
News |
Published 28 November 2024
In 2025, the European Partnership on One Health AntiMicrobial Resistance, EUP OHAMR, is starting a new collaboration for research into antimicrobialresistance, supported by the European Commission. The EUP OHAMR offers great opportunities, both for r...
-
News |
Published 21 November 2023
Research is an important component of society’s efforts to prevent and manage antibiotic resistance. Next year, the Swedish Research Council will for the first time issue a call for project grants in this area, open to applicants from different scien...
Keywords:
-
News |
Published 8 September 2023
In early 2021, a call will open within the Joint Programme Initiative on Antimicrobial Resistance (JPIAMR) collaboration, focusing on preventing and reducing the development and transmission of antimicrobial resistance. The Swedish Research Council a...
Keywords: